BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.34.2//EN
X-ORIGINAL-URL:https://www.cac2.org/
X-WR-CALNAME:CAC2
X-WR-CALDESC:Coalition Against Childhood Cancer
X-WR-TIMEZONE:America/New_York
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T030000
RRULE:FREQ=YEARLY;BYMONTH=03;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T010000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-07614251f62899912b42cf137c9b7a3e@cac2.org
DTSTART;TZID=America/New_York:20220915T000100
DTEND;TZID=America/New_York:20220915T235900
DTSTAMP:20250623T142924Z
CREATED:20250623
LAST-MODIFIED:20260506
PRIORITY:5
SEQUENCE:0
TRANSP:OPAQUE
SUMMARY:Meeting on Reducing Cardiac Late Effects in Pediatric Cancer Survivors
DESCRIPTION:Children’s Cancer Cause is hosting a virtual externally-led Patient-Focused Drug Development (PFDD) meeting on Reducing Cardiac Late Effects in Pediatric Cancer Survivors, on September 15, 2022. The conference is an opportunity for survivors and caregivers to educate representatives of the FDA, academic researchers, and pharmaceutical companies about their personal experiences managing the impact of cardiac late effects on daily living and long-term health.\nThe PFDD Program was created by the FDA several years ago as a mechanism to more systematically gather information from patients and survivors about their conditions, available therapies, and what matters most to them in balancing risks and benefits. This information helps inform FDA’s drug development decision making process.\nAn important focus of this cardiac-focused PFDD is to explore the impact of pediatric cancer therapies among minority groups at higher risk for developing cardiotoxicities. Recent data indicate that pediatric cancer survivors of African ancestry appear to be disproportionately affected by cardiomyopathy. These findings are consistent with larger trends on health disparities among minority groups and deserve focused discussion to advance understanding of the late sequelae of cancer therapy in these children.\nIf you are interested in participating in the cardiac late effects meeting, please visit www.childhoodcancerpfdd.org/cardiac-effects and fill out the interest form to be notified when registration is live.\n
URL:https://www.cac2.org/cac2c-events/meeting-on-reducing-cardiac-late-effects-in-pediatric-cancer-survivors/
ORGANIZER;CN=Children's Cancer Cause:MAILTO:jkean@childrenscause.org
CATEGORIES:Community Event,Member Events,Virtual Event
LOCATION:Washington DC
ATTACH;FMTTYPE=image/png:https://www.cac2.org/wp-content/uploads/2025/06/PFDD_SavetheDate_20221.png
END:VEVENT
END:VCALENDAR